Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$42,907,212
+$9,831,364 QoQ
Shares Held
35,773
-0.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
3.69%
of 13F equity value
Holder Rank
#589
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Colonial Trust Advisors holds $80,602,138 across 14 Drug Manufacturers - General names. LLY ranks #1 (53.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
35,773 | $42,907,212 | |
| 2 | JNJ |
Johnson & Johnson
|
134,256 | $34,096,996 | |
| 3 | MRK |
Merck & Co., Inc.
|
8,658 | $1,112,553 | |
| 4 | AMGN |
Amgen Inc
|
2,503 | $906,386 | |
| 5 | ABBV |
AbbVie Inc.
|
3,104 | $781,090 | |
| 6 | NVS |
Novartis AG
|
1,390 | $217,840 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,467 | $199,768 | |
| 8 | NVO |
Novo Nordisk A S
|
3,581 | $171,673 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,907,212 | 35,773 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $33,075,848 | 35,961 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $39,392,399 | 36,655 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $28,213,451 | 36,977 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $29,096,736 | 37,326 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $30,354,670 | 36,753 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $28,421,952 | 36,816 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $33,470,813 | 37,780 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $33,482,763 | 36,982 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $30,212,854 | 38,836 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $23,114,526 | 39,653 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $23,046,636 | 42,907 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $21,672,972 | 46,213 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $16,475,917 | 47,976 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $18,231,270 | 49,834 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $16,229,259 | 50,191 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $16,084,401 | 49,608 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $14,500,344 | 50,635 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $14,105,174 | 51,065 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $12,106,788 | 52,399 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $12,139,083 | 52,889 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $9,910,240 | 53,047 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $9,288,057 | 55,011 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $7,904,712 | 53,403 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $8,795,450 | 53,572 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $7,331,490 | 52,851 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||